Association between Adverse Maternal Clinical Outcomes and Imbalance of Cytokines and Angiogenic Factors in Preterm Preeclampsia

Abstract Objective Preeclampsia (PE) is a pregnancy-specific syndrome characterized by abnormal levels of cytokines and angiogenic factors, playing a role in the disease development. The present study evaluated whether immunological markers are associated with the gestational age and with the disease severity in preeclamptic women. Methods Ninety-five women who developed PE were stratified for gestational age as preterm PE (< 37 weeks) and term PE (≥ 37 weeks of gestation) and compared for disease severity as well as plasma concentration of angiogenic factors and cytokines. The concentrations of placental growth factor (PlGF), vascular endothelial growth factor (VEGF), Fms-like soluble tyrosine kinase (sFlt-1) and soluble endoglin (sEng), as well as the cytokines, tumor necrosis factor-α (TNF-α) and interleukin 10 (IL-10), were determined by enzyme-linked immunosorbent assay (ELISA). Results The comparison between preeclamptic groups showed a higher percentage of severe cases in preterm PE (82.1%) than in term PE (35.9%). Similarly, the concentrations of TNF-α, sFlt-1, and sEng, as well as TNF-α/IL-10 and sFlt-1/PlGF ratios were significantly higher in the preterm PE group. In contrast, concentrations of PlGF, VEGF, and IL-10 were significantly lower in women with preterm PE. Negative correlations between TNF-α and IL-10 (r = 0.5232) and between PlGF and sFlt1 (r = 0.4158) were detected in the preterm PE. Conclusion In pregnant women with preterm PE, there is an imbalance between immunological markers, with the predominance of anti-angiogenic factors and TNF-α, associated with adverse maternal clinical outcomes.

Saved in:
Bibliographic Details
Main Authors: Nunes,Priscila Rezeck, Romao-Veiga,Mariana, Borges,Vera Therezinha Medeiros, Matias,Mariana Leticia, Ribeiro,Vanessa Rocha, Costa,Roberto Antonio Araujo, Peracoli,Maria Terezinha Serrao, Peracoli,Jose Carlos
Format: Digital revista
Language:English
Published: Federação Brasileira das Sociedades de Ginecologia e Obstetrícia 2021
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032021000900669
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0100-72032021000900669
record_format ojs
spelling oai:scielo:S0100-720320210009006692021-11-25Association between Adverse Maternal Clinical Outcomes and Imbalance of Cytokines and Angiogenic Factors in Preterm PreeclampsiaNunes,Priscila RezeckRomao-Veiga,MarianaBorges,Vera Therezinha MedeirosMatias,Mariana LeticiaRibeiro,Vanessa RochaCosta,Roberto Antonio AraujoPeracoli,Maria Terezinha SerraoPeracoli,Jose Carlos angiogenic factors clinical adverse outcomes cytokines preterm preeclampsia term preeclampsia Abstract Objective Preeclampsia (PE) is a pregnancy-specific syndrome characterized by abnormal levels of cytokines and angiogenic factors, playing a role in the disease development. The present study evaluated whether immunological markers are associated with the gestational age and with the disease severity in preeclamptic women. Methods Ninety-five women who developed PE were stratified for gestational age as preterm PE (< 37 weeks) and term PE (≥ 37 weeks of gestation) and compared for disease severity as well as plasma concentration of angiogenic factors and cytokines. The concentrations of placental growth factor (PlGF), vascular endothelial growth factor (VEGF), Fms-like soluble tyrosine kinase (sFlt-1) and soluble endoglin (sEng), as well as the cytokines, tumor necrosis factor-α (TNF-α) and interleukin 10 (IL-10), were determined by enzyme-linked immunosorbent assay (ELISA). Results The comparison between preeclamptic groups showed a higher percentage of severe cases in preterm PE (82.1%) than in term PE (35.9%). Similarly, the concentrations of TNF-α, sFlt-1, and sEng, as well as TNF-α/IL-10 and sFlt-1/PlGF ratios were significantly higher in the preterm PE group. In contrast, concentrations of PlGF, VEGF, and IL-10 were significantly lower in women with preterm PE. Negative correlations between TNF-α and IL-10 (r = 0.5232) and between PlGF and sFlt1 (r = 0.4158) were detected in the preterm PE. Conclusion In pregnant women with preterm PE, there is an imbalance between immunological markers, with the predominance of anti-angiogenic factors and TNF-α, associated with adverse maternal clinical outcomes.info:eu-repo/semantics/openAccessFederação Brasileira das Sociedades de Ginecologia e ObstetríciaRevista Brasileira de Ginecologia e Obstetrícia v.43 n.9 20212021-09-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032021000900669en10.1055/s-0041-1735157
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Nunes,Priscila Rezeck
Romao-Veiga,Mariana
Borges,Vera Therezinha Medeiros
Matias,Mariana Leticia
Ribeiro,Vanessa Rocha
Costa,Roberto Antonio Araujo
Peracoli,Maria Terezinha Serrao
Peracoli,Jose Carlos
spellingShingle Nunes,Priscila Rezeck
Romao-Veiga,Mariana
Borges,Vera Therezinha Medeiros
Matias,Mariana Leticia
Ribeiro,Vanessa Rocha
Costa,Roberto Antonio Araujo
Peracoli,Maria Terezinha Serrao
Peracoli,Jose Carlos
Association between Adverse Maternal Clinical Outcomes and Imbalance of Cytokines and Angiogenic Factors in Preterm Preeclampsia
author_facet Nunes,Priscila Rezeck
Romao-Veiga,Mariana
Borges,Vera Therezinha Medeiros
Matias,Mariana Leticia
Ribeiro,Vanessa Rocha
Costa,Roberto Antonio Araujo
Peracoli,Maria Terezinha Serrao
Peracoli,Jose Carlos
author_sort Nunes,Priscila Rezeck
title Association between Adverse Maternal Clinical Outcomes and Imbalance of Cytokines and Angiogenic Factors in Preterm Preeclampsia
title_short Association between Adverse Maternal Clinical Outcomes and Imbalance of Cytokines and Angiogenic Factors in Preterm Preeclampsia
title_full Association between Adverse Maternal Clinical Outcomes and Imbalance of Cytokines and Angiogenic Factors in Preterm Preeclampsia
title_fullStr Association between Adverse Maternal Clinical Outcomes and Imbalance of Cytokines and Angiogenic Factors in Preterm Preeclampsia
title_full_unstemmed Association between Adverse Maternal Clinical Outcomes and Imbalance of Cytokines and Angiogenic Factors in Preterm Preeclampsia
title_sort association between adverse maternal clinical outcomes and imbalance of cytokines and angiogenic factors in preterm preeclampsia
description Abstract Objective Preeclampsia (PE) is a pregnancy-specific syndrome characterized by abnormal levels of cytokines and angiogenic factors, playing a role in the disease development. The present study evaluated whether immunological markers are associated with the gestational age and with the disease severity in preeclamptic women. Methods Ninety-five women who developed PE were stratified for gestational age as preterm PE (< 37 weeks) and term PE (≥ 37 weeks of gestation) and compared for disease severity as well as plasma concentration of angiogenic factors and cytokines. The concentrations of placental growth factor (PlGF), vascular endothelial growth factor (VEGF), Fms-like soluble tyrosine kinase (sFlt-1) and soluble endoglin (sEng), as well as the cytokines, tumor necrosis factor-α (TNF-α) and interleukin 10 (IL-10), were determined by enzyme-linked immunosorbent assay (ELISA). Results The comparison between preeclamptic groups showed a higher percentage of severe cases in preterm PE (82.1%) than in term PE (35.9%). Similarly, the concentrations of TNF-α, sFlt-1, and sEng, as well as TNF-α/IL-10 and sFlt-1/PlGF ratios were significantly higher in the preterm PE group. In contrast, concentrations of PlGF, VEGF, and IL-10 were significantly lower in women with preterm PE. Negative correlations between TNF-α and IL-10 (r = 0.5232) and between PlGF and sFlt1 (r = 0.4158) were detected in the preterm PE. Conclusion In pregnant women with preterm PE, there is an imbalance between immunological markers, with the predominance of anti-angiogenic factors and TNF-α, associated with adverse maternal clinical outcomes.
publisher Federação Brasileira das Sociedades de Ginecologia e Obstetrícia
publishDate 2021
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032021000900669
work_keys_str_mv AT nunespriscilarezeck associationbetweenadversematernalclinicaloutcomesandimbalanceofcytokinesandangiogenicfactorsinpretermpreeclampsia
AT romaoveigamariana associationbetweenadversematernalclinicaloutcomesandimbalanceofcytokinesandangiogenicfactorsinpretermpreeclampsia
AT borgesveratherezinhamedeiros associationbetweenadversematernalclinicaloutcomesandimbalanceofcytokinesandangiogenicfactorsinpretermpreeclampsia
AT matiasmarianaleticia associationbetweenadversematernalclinicaloutcomesandimbalanceofcytokinesandangiogenicfactorsinpretermpreeclampsia
AT ribeirovanessarocha associationbetweenadversematernalclinicaloutcomesandimbalanceofcytokinesandangiogenicfactorsinpretermpreeclampsia
AT costarobertoantonioaraujo associationbetweenadversematernalclinicaloutcomesandimbalanceofcytokinesandangiogenicfactorsinpretermpreeclampsia
AT peracolimariaterezinhaserrao associationbetweenadversematernalclinicaloutcomesandimbalanceofcytokinesandangiogenicfactorsinpretermpreeclampsia
AT peracolijosecarlos associationbetweenadversematernalclinicaloutcomesandimbalanceofcytokinesandangiogenicfactorsinpretermpreeclampsia
_version_ 1756389844877049856